Status:
COMPLETED
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This project proposes to conduct the first study of the predictive utility of olfactory hedonic measurement for targeted psychosocial rehabilitation in schizophrenia. The information gathered from the...
Eligibility Criteria
Inclusion
- age 18 to 65;
- DSM-5 diagnosis of schizophrenia or schizoaffective or schizophreniform disorder
Exclusion
- the presence of a current organic brain syndrome;
- a current and severe substance use disorder (DSM-5);
- intellectual disability (DSM-5)
Key Trial Info
Start Date :
September 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT05282186
Start Date
September 2 2022
End Date
May 31 2025
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215